NCT00102466View on ClinicalTrials.gov

Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

1,007

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

DRUG

Gliclazide

DRUG

Metformin

Trial Locations (2)

Unknown

Investigative Centers, Nuremberg

Novartis Pharmaceuticals, Basel

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY